Tirzepatide, a novel medication, is creating considerable excitement within the medical community. It operates differently from existing diabetes therapies , targeting multiple receptors involved in glucose regulation and hunger . Initial research have demonstrated significant efficacy in controlling blood glucose in individuals with type 2 diabete